1. EXECUTIVE SUMMARY
2. MARKET SNAPSHOT
2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation
3. BUSINESS LANDSCAPE
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter’s Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations
3.8. Product Pipeline Analysis
3.9. Incidence and Prevalence Analysis
3.10. Patent Analysis
4. TECHNOLOGICAL OUTLOOK
5. BIOENGINEERED PROTEINS AND ENZYMES MARKET BY PRODUCT TYPE
5.1. Introduction
5.2. Recombinant Proteins
5.3. Therapeutic Proteins
5.4. Industrial Enzymes
5.5. Diagnostic Enzymes
5.6. Specialty Proteins
5.7. Biosimilars
6. BIOENGINEERED PROTEINS AND ENZYMES MARKET BY APPLICATION
6.1. Introduction
6.2. Biopharmaceuticals
6.3. Diagnostics & Research
6.4. Food & Beverages
6.5. Animal Feed & Nutrition
6.6. Biofuels & Energy
6.7. Detergents & Textiles
6.8. Agriculture & Crop Protection
6.9. Cosmetics & Personal Care
6.10. Environmental Biotechnology
7. BIOENGINEERED PROTEINS AND ENZYMES MARKET BY END-USER
7.1. Introduction
7.2. Pharmaceutical & Biotechnology Companies
7.3. Contract Research and Manufacturing Organizations (CROs/CDMOs)
7.4. Academic and Research Institutions
7.5. Industrial Manufacturers
7.6. Food & Beverage Manufacturers
7.7. Agriculture & Livestock Firms
8. BIOENGINEERED PROTEINS AND ENZYMES MARKET BY GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. USA
8.2.2. Canada
8.2.3. Mexico
8.3. South America
8.3.1. Brazil
8.3.2. Argentina
8.3.3. Others
8.4. Europe
8.4.1. United Kingdom
8.4.2. Germany
8.4.3. France
8.4.4. Spain
8.4.5. Others
8.5. Middle East and Africa
8.5.1. Saudi Arabia
8.5.2. UAE
8.5.3. Others
8.6. Asia Pacific
8.6.1. China
8.6.2. India
8.6.3. Japan
8.6.4. South Korea
8.6.5. Indonesia
8.6.6. Thailand
8.6.7. Others
9. COMPETITIVE ENVIRONMENT AND ANALYSIS
9.1. Major Players and Strategy Analysis
9.2. Market Share Analysis
9.3. Mergers, Acquisitions, Agreements, and Collaborations
9.4. Competitive Dashboard
10. COMPANY PROFILES
10.1. Thermo Fisher Scientific Inc.
10.2. Merck KGaA
10.3. Bio-Techne Corporation
10.4. Abcam plc
10.5. GenScript Biotech Corporation
10.6. Sino Biological Inc.
10.7. Novonesis
10.8. Codexis, Inc.
10.9. BASF SE
10.10. Advanced Enzyme Technologies Ltd.
11. APPENDIX
11.1. Currency
11.2. Assumptions
11.3. Base and Forecast Years Timeline
11.4. Key benefits for the stakeholders
11.5. Research Methodology
11.6. Abbreviations